Genetic Determinants of Drug-Induced Agranulocytosis: Potential Risk of Olanzapine? - Dettling, M; Cascorbi, I; Hellweg, R; Deicke, U; Weise, L; Müller-Oerlinghausen, B (Pharmacopsychiatry, 1999)